From: Statistical methods for constructing disease comorbidity networks from longitudinal inpatient data
Rank | Raw | OER | phi | DF | IPFP | GloSS | Salience |
---|---|---|---|---|---|---|---|
1 | 7: 15.7% | 11: 18.9% | 7: 17.2% | 7: 17.5% | 17: 27.0% | 7: 17.7% | 11: 35.0% |
2 | 3: 9.1% | 17: 9.7% | 3: 9.0% | 3: 12.9% | 1: 13.0% | 3: 11.1% | 7: 24.7% |
3 | 9: 8.9% | 2: 9.0% | 8: 9.0% | 9: 10.5% | 2: 12.2% | 4: 8.8% | 6: 20.1% |
4 | 8: 8.9% | 10: 8.2% | 6: 8.8% | 8: 9.4% | 11: 11.2% | 9: 8.5% | 3: 9.4% |
5 | 6: 8.3% | 6: 7.6% | 9: 8.6% | 6: 8.4% | 6: 6.2% | 8: 8.5% | 17: 3.4% |
6 | 10: 8.0% | 15: 7.1% | 10: 8.0% | 10: 8.3% | 15: 5.3% | 11: 6.8% | 2: 1.9% |
7 | 16: 7.0% | 8: 7.0% | 16: 6.7% | 16: 6.0% | 8: 3.9% | 6: 5.7% | 8: 1.6% |
8 | 17: 6.3% | 9: 5.2% | 5: 4.9% | 17: 5.6% | 10: 3.9% | 17: 5.4% | 13: 1.6% |
9 | 13: 5.2% | 7: 5.2% | 13: 4.9% | 13: 4.3% | 3: 2.8% | 1: 5.3% | 10: 0.9% |
10 | 5: 4.8% | 5: 3.8% | 17: 4.8% | 5: 4.2% | 14: 2.7% | 16: 4.9% | 5: 0.5% |
11 | 4: 4.6% | 14: 3.6% | 4: 4.6% | 4: 4.1% | 7: 2.7% | 13: 4.6% | 9: 0.5% |
12 | 2: 4.3% | 13: 3.5% | 11: 4.5% | 2: 3.5% | 9: 2.6% | 5: 4.0% | 4: 0.2% |
13 | 1: 3.8% | 1: 3.4% | 2: 3.4% | 1: 2.2% | 5: 2.5% | 10: 3.9% | 1: 0.1% |
14 | 11: 2.4% | 16: 3.1% | 1: 3.1% | 11: 2.0% | 12: 1.8% | 2: 3.8% | 14: 0.1% |
15 | 12: 2.2% | 3: 2.8% | 12: 2.1% | 12: 1.2% | 13: 1.5% | 12: 1.0% | 12: 0.0% |
16 | 14: 0.4% | 12: 1.6% | 15: 0.2% | 15: 0.0% | 16: 0.6% | 15: 0.1% | 15: 0.0% |
17 | 15: 0.1% | 4: 0.1% | 14: 0.0% | 14: 0.0% | 4: 0.2% | 14: 0.0% | 16: 0.0% |